The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
News|Articles|June 2, 2004
- Pharmaceutical Technology-06-02-2004
- Volume 28
- Issue 6
Will CROs Take On the Risks of Strategic Outsourcing?
Author(s)Jim Miller
It's not clear whether contract service providers can deliver the performance improvements and costs savings that drug companies expect from large, long-term, semi-exclusive contracts.
Advertisement
Articles in this issue
over 22 years ago
Microbial Testing in Support of Aseptic Processingover 22 years ago
June 2004over 22 years ago
Uniformity of Bioprocessing Equipment Manufacturingover 22 years ago
Research Tips To Find Packaging Facts Fastover 22 years ago
New Technologies Optimize Biotech Process Efficiencyover 22 years ago
Battles Escalate Over Prescription Drug Importsover 22 years ago
USP's Semi-Hemiquinquennial Meetingover 22 years ago
In the Spotlight - June 2004Advertisement
Related to this article
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
What the Olanzapine Depot Approval Means for CMC Teams
3
Complying with International Pharmacopoeias
4
CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care
5